Am. S. C. R. No. 9 Summary

• Designates the month of March as Cardiac Amyloidosis Recognition Month in Ohio

• Amyloidosis is a disease in which abnormal proteins build up in body tissues and organs, including the heart, causing progressive organ dysfunction and complications like shortness of breath, fluid buildup, and swelling

• Two proteins cause the vast majority of cardiac amyloidosis cases: transthyretin (which can be hereditary with a genetic mutation present in approximately 3% of individuals of African descent, or acquired and associated with aging and more common in men) or light chains

• Most patients with cardiac amyloidosis remain undiagnosed for many years or never receive proper diagnosis because the disease is rare, early symptoms are nonspecific, and many clinicians are unfamiliar with diagnostic tools and tests

• Resolution encourages clinician education about screening for cardiac amyloidosis, applauds support organizations like the Amyloidosis Foundation, and encourages funding and removal of barriers to quality medical care and coverage for underserved populations